Our new programme to help the UK turn world-class biomedical research into patient benefit, faster.
The UK has exceptional biomedical science. But too often, promising discoveries take too long to reach patients because the pathway from research to adoption is fragmented.
Our translational catalyst programme brings together academia, industry, the NHS, regulators, funders and investors to tackle the barriers that slow translation.Together, we can strengthen the system that turns world-class research into patient benefit.
We are seeking a small number of founding partners to help shape and scale this independent, cross-sector initiative.
The challenge: turning discovering into patient benefit
The UK excels at discovery. Turning that discovery into patient benefit remains more challenging.
Across the innovation pathway, organisations often work towards the same goal through separate processes, creating delays, duplication and missed opportunities. As a result:
- promising innovations stall before reaching patients
- development becomes slower and more costly
- investment opportunities are harder to realise
- the NHS is slower to benefit from new advances
- the UK risks losing competitiveness in a rapidly evolving global landscape.
These challenges are well understood. In March 2026, the Academy brought together senior leaders from across UK life sciences, alongside the Medical Research Council and the National Centre for Universities and Business. The consensus was clear: the UK now needs practical mechanisms for coordinated action across the translational pathway.
Why now?
The coming years will be pivotal for UK life sciences. Advances in areas such as precision medicine, genomics, advanced therapies, AI-enabled research and clinical innovation have the potential to transform healthcare and deliver long-term public and economic benefit.
To turn that potential into reality, we need a system that supports collaboration as effectively as it supports discovery. The UK does not simply need more innovation. It needs a stronger environment in which innovation can flourish.
Join us
The UK has the science, the talent and the ambition to lead globally in biomedical innovation. The next step is to ensure the system works as effectively as the science itself.
Our translational catalyst programme is designed to help make that happen. Become a founding partner and help build the conditions that allow world-class science into patient benefit, faster.